New observations suggest that the brains of HD mutation carriers consume energy differently. Do we care? (Yes!)
Final results from the TRACK-HD study show very specific changes in HD. We're ready for trials: bring on the drugs!
New study shows a blood chemical called '8OHdG' is not a good biomarker for HD. Bad news?
Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013
Follow-up data from TRACK-HD study proves that we have the tests we need to successfully run drug trials for HD
HDAC inhibitors explained, plus how new HDAC-related Huntington's disease research might help us find biomarkers
HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc
Merger of two major Huntington’s Disease observational trials creates ENROLL-HD
The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers